Microglia communication: Parallels between aging and Alzheimer's disease

Clinical and Experimental Neuroimmunology

Volumn 7, Issue 2, 2016, Pages 114-125

  Udeochu, Joe C ^a   Shea, Jeremy M ^a   Villeda, Saul A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; Alzheimer's disease; microglia; neuroinflammation

Indexed keywords

COMPLEMENT FACTOR; CYTOKINE;

AGING; ALZHEIMER DISEASE; CELL ACTIVATION; CELL COMMUNICATION; CELL STRUCTURE; ENCEPHALITIS; EXOSOME; HUMAN; LEARNING; MEMORY; MICROGLIA; NERVE CELL PLASTICITY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW;

EID: 84964727728     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/cen3.12307     Document Type: Review

References (106)

1. Ransohoff RM, Perry VH,. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 2009; 27: 119-45.
2. Kierdorf K, Prinz M,. Factors regulating microglia activation. Front Cell Neurosci. 2013; 7: 44.
3. Perdiguero EG, Geissmann F,. The development and maintenance of resident macrophages. Nat Immunol. 2015; 17: 2-8.
4. Sierra A, Encinas JM, Deudero JJ, et al., Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell. 2010; 7: 483-95.
5. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J,. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 2013; 36: 209-17.
6. Parkhurst CN, Yang G, Ninan I, et al., Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013; 155: 1596-609.
7. Salter MW, Beggs S,. Sublime microglia: expanding roles for the guardians of the CNS. Cell. 2014; 158: 15-24.
8. Nimmerjahn A, Kirchhoff F, Helmchen F,. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005; 308: 1314-8.
9. Davalos D, Grutzendler J, Yang G, et al., ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005; 8: 752-8.
10. Mosher KI, Wyss-Coray T,. Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol. 2014; 88: 594-604.
11. Fenn AM, Henry CJ, Huang Y, Dugan A, Godbout JP,. Lipopolysaccharide-induced interleukin (IL)-4 receptor-alpha expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice. Brain Behav Immun. 2012; 26: 766-77.
12. Crain JM, Nikodemova M, Watters JJ,. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J Neurosci Res. 2013; 91: 1143-51.
13. Ye SM, Johnson RW,. Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol. 1999; 93: 139-48.
14. Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K,. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia. 2007; 55: 412-24.
15. Cho SH, Chen JA, Sayed F, et al., SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1beta. J Neurosci. 2015; 35: 807-18.
16. Orre M, Kamphuis W, Osborn LM, et al., Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Neurobiol Aging. 2014; 35: 2746-60.
17. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P,. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol. 2009; 210: 3-12.
18. Yates SL, Burgess LH, Kocsis-Angle J, et al., Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J Neurochem. 2000; 74: 1017-25.
19. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP,. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation. 2006; 3: 27.
20. Orre M, Kamphuis W, Osborn LM, et al., Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiol Aging. 2014; 35: 1-14.
21. Holtman IR, Raj DD, Miller JA, et al., Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun. 2015; 3: 31.
22. Grabert K, Michoel T, Karavolos MH, et al., Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat Neurosci. 2016; 19: 504-16.
23. Perry VH, Holmes C,. Microglial priming in neurodegenerative disease. Nat Rev Neurol. 2014; 10: 217-24.
24. Hickman SE, Kingery ND, Ohsumi TK, et al., The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. 2013; 16: 1896-905.
25. Molina H, Holers VM, Li B, et al., Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci U S A. 1996; 93: 3357-61.
26. Ricklin D, Hajishengallis G, Yang K, Lambris JD,. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010; 11: 785-97.
27. Stevens B, Allen NJ, Vazquez LE, et al., The classical complement cascade mediates CNS synapse elimination. Cell. 2007; 131: 1164-78.
28. Veerhuis R, Janssen I, De Groot CJ, Van Muiswinkel FL, Hack CE, Eikelenboom P,. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol. 1999; 160: 289-99.
29. Veerhuis R,. Histological and direct evidence for the role of complement in the neuroinflammation of AD. Curr Alzheimer Res. 2011; 8: 34-58.
30. Veerhuis R, Nielsen HM, Tenner AJ,. Complement in the brain. Mol Immunol. 2011; 48: 1592-603.
31. Bonifati DM, Kishore U,. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol. 2007; 44: 999-1010.
32. Reichwald J, Danner S, Wiederhold KH, Staufenbiel M,. Expression of complement system components during aging and amyloid deposition in APP transgenic mice. J Neuroinflammation. 2009; 6: 35.
33. Fu H, Liu B, Frost JL, et al., Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Abeta by microglia. Glia. 2012; 60: 993-1003.
34. Cribbs DH, Berchtold NC, Perreau V, et al., Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation. 2012; 9: 179.
35. Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ,. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-beta neurotoxicity. J Biol Chem. 2013; 288: 654-65.
36. Rogers J, Cooper NR, Webster S, et al., Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1992; 89: 10016-20.
37. Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ,. Beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol. 1994; 152: 5050-9.
38. Shen Y, Lue L, Yang L, et al., Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci Lett. 2001; 305: 165-8.
39. Lambert JC, Heath S, Even G, et al., Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009; 41: 1094-9.
40. Stephan AH, Madison DV, Mateos JM, et al., A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci. 2013; 33: 13460-74.
41. Zappulli V, Friis KP, Fitzpatrick Z, Maguire CA, Breakefield XO,. Extracellular vesicles and intercellular communication within the nervous system. J Clin Invest. 2016; 126: 1198-207.
42. Vella LJ, Sharples RA, Nisbet RM, Cappai R, Hill AF,. The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J. 2008; 37: 323-32.
43. Coleman BM, Hill AF,. Extracellular vesicles-Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases. Semin Cell Dev Biol. 2015; 40: 89-96.
44. Rajendran L, Honsho M, Zahn TR, et al., Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A. 2006; 103: 11172-7.
45. Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E,. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2014; 35: 1792-800.
46. Fruhbeis C, Frohlich D, Kuo WP, et al., Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol. 2013; 11: e1001604.
47. Yuyama K, Sun H, Mitsutake S, Igarashi Y,. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-beta by microglia. J Biol Chem. 2012; 287: 10977-89.
48. Asai H, Ikezu S, Tsunoda S, et al., Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015; 18: 1584-93.
49. Thery C, Ostrowski M, Segura E,. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9: 581-93.
50. Raposo G, Stoorvogel W,. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013; 200: 373-83.
51. Potolicchio I, Carven GJ, Xu X, et al., Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol. 2005; 175: 2237-43.
52. Bianco F, Perrotta C, Novellino L, et al., Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 2009; 28: 1043-54.
53. Cossetti C, Iraci N, Mercer TR, et al., Extracellular vesicles from neural stem cells transfer IFN-gamma via Ifngr1 to activate Stat1 signaling in target cells. Mol Cell. 2014; 56: 193-204.
54. Kucharzewska P, Christianson HC, Welch JE, et al., Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013; 110: 7312-7.
55. Kreutzberg GW,. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996; 19: 312-8.
56. Vaughan DW, Peters A,. Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J Neurocytol. 1974; 3: 405-29.
57. Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN, Wong WT,. Age-related alterations in the dynamic behavior of microglia. Aging Cell. 2011; 10: 263-76.
58. Tremblay ME, Zettel ML, Ison JR, Allen PD, Majewska AK,. Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia. 2012; 60: 541-58.
59. Lively S, Schlichter LC,. The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. J Neuroinflammation. 2013; 10: 75.
60. Milner R, Campbell IL,. The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol. 2003; 170: 3850-8.
61. Halleskog C, Mulder J, Dahlstrom J, et al., WNT signaling in activated microglia is proinflammatory. Glia. 2011; 59: 119-31.
62. Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA,. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci. 2008; 28: 6333-41.
63. Richard KL, Filali M, Prefontaine P, Rivest S,. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci. 2008; 28: 5784-93.
64. Song WC,. Crosstalk between complement and toll-like receptors. Toxicol Pathol. 2012; 40: 174-82.
65. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M,. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci. 2005; 29: 381-93.
66. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D,. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol. 1989; 24: 173-82.
67. Baron R, Babcock AA, Nemirovsky A, Finsen B, Monsonego A,. Accelerated microglial pathology is associated with Abeta plaques in mouse models of Alzheimer's disease. Aging Cell. 2014; 13: 584-95.
68. Hefendehl JK, Neher JJ, Suhs RB, Kohsaka S, Skodras A, Jucker M,. Homeostatic and injury-induced microglia behavior in the aging brain. Aging Cell. 2014; 13: 60-9.
69. Haynes SE, Hollopeter G, Yang G, et al., The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci. 2006; 9: 1512-9.
70. Orr AG, Orr AL, Li XJ, Gross RE, Traynelis SF,. Adenosine A(2A) receptor mediates microglial process retraction. Nat Neurosci. 2009; 12: 872-8.
71. Koizumi S, Ohsawa K, Inoue K, Kohsaka S,. Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors. Glia. 2013; 61: 47-54.
72. Krabbe G, Halle A, Matyash V, et al., Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS ONE. 2013; 8: e60921.
73. Koenigsknecht-Talboo J, Meyer-Luehmann M, Parsadanian M, et al., Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice. J Neurosci. 2008; 28: 14156-64.
74. Condello C, Yuan P, Schain A, Grutzendler J,. Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques. Nat Commun. 2015; 6: 6176.
75. Xu H, Chen M, Manivannan A, Lois N, Forrester JV,. Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell. 2008; 7: 58-68.
76. Nakanishi H, Hayashi Y, Wu Z,. The role of microglial mtDNA damage in age-dependent prolonged LPS-induced sickness behavior. Neuron Glia Biol. 2011; 7: 17-23.
77. Ma W, Coon S, Zhao L, Fariss RN, Wong WT,. A2E accumulation influences retinal microglial activation and complement regulation. Neurobiol Aging. 2013; 34: 943-60.
78. Ma W, Cojocaru R, Gotoh N, et al., Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation. Neurobiol Aging. 2013; 34: 2310-21.
79. Li W,. Phagocyte dysfunction, tissue aging and degeneration. Ageing Res Rev. 2013; 12: 1005-12.
80. Ritzel RM, Patel AR, Pan S, et al., Age- and location-related changes in microglial function. Neurobiol Aging. 2015; 36: 2153-63.
81. Floden AM, Combs CK,. Microglia demonstrate age-dependent interaction with amyloid-beta fibrils. J Alzheimers Dis. 2011; 25: 279-93.
82. Bolmont T, Haiss F, Eicke D, et al., Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J Neurosci. 2008; 28: 4283-92.
83. Burke SN, Barnes CA,. Neural plasticity in the ageing brain. Nat Rev Neurosci. 2006; 7: 30-40.
84. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G,. The hallmarks of aging. Cell. 2013; 153: 1194-217.
85. Paolicelli RC, Bolasco G, Pagani F, et al., Synaptic pruning by microglia is necessary for normal brain development. Science. 2011; 333: 1456-8.
86. Schafer DP, Lehrman EK, Kautzman AG, et al., Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012; 74: 691-705.
87. Sipe GO, Lowery RL, Tremblay ME, Kelly EA, Lamantia CE, Majewska AK,. Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nat Commun. 2016; 7: 10905.
88. Roumier A, Bechade C, Poncer JC, et al., Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J Neurosci. 2004; 24: 11421-8.
89. Rogers JT, Morganti JM, Bachstetter AD, et al., CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci. 2011; 31: 16241-50.
90. Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, Lynch MA,. The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem. 2006; 99: 1263-72.
91. Cox FF, Carney D, Miller AM, Lynch MA,. CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav Immun. 2012; 26: 789-96.
92. Heppner FL, Ransohoff RM, Becher B,. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015; 16: 358-72.
93. Heneka MT, Kummer MP, Stutz A, et al., NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 2013; 493: 674-8.
94. Guerreiro R, Wojtas A, Bras J, et al., TREM2 variants in Alzheimer's disease. N Engl J Med. 2013; 368: 117-27.
95. Jonsson T, Stefansson H, Steinberg S, et al., Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med. 2013; 368: 107-16.
96. Bradshaw EM, Chibnik LB, Keenan BT, et al., CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013; 16: 848-50.
97. Zhang B, Gaiteri C, Bodea LG, et al., Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013; 153: 707-20.
98. Chan G, White CC, Winn PA, et al., CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci. 2015; 18: 1556-8.
99. Zhong L, Chen XF, Zhang ZL, et al., DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response. J Biol Chem. 2015; 290: 15866-77.
100. Shi Q, Colodner KJ, Matousek SB, et al., Complement C3-deficient mice fail to display age-related hippocampal decline. J Neurosci. 2015; 35: 13029-42.
101. Fonseca MI, Zhou J, Botto M, Tenner AJ,. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J Neurosci. 2004; 24: 6457-65.
102. Hong S, Beja-Glasser VF, Nfonoyim BM, et al., Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016; pii: aad8373.
103. Bahrini I, Song JH, Diez D, Hanayama R,. Neuronal exosomes facilitate synaptic pruning by up-regulating complement factors in microglia. Sci Rep. 2015; 5: 7989.
104. Cho SH, Sun B, Zhou Y, et al., CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem. 2011; 286: 32713-22.
105. Barrientos RM, Kitt MM, Watkins LR, Maier SF,. Neuroinflammation in the normal aging hippocampus. Neuroscience. 2015; 309: 84-99.
106. Johansson JU, Woodling NS, Wang Q, et al., Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. J Clin Invest. 2015; 125: 350-64.